Two Seas Capital LP Lucid Diagnostics Inc. Transaction History
Two Seas Capital LP
- $5.03 Billion
- Q3 2025
A detailed history of Two Seas Capital LP transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Two Seas Capital LP holds 3,000,000 shares of LUCD stock, worth $3.24 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,000,000Holding current value
$3.24 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding LUCD
# of Institutions
82Shares Held
31.1MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.52MShares$4.89 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA4MShares$4.32 Million0.15% of portfolio
-
Awm Investment Company, Inc. New York, NY2.99MShares$3.23 Million0.37% of portfolio
-
Ghisallo Capital Management LLC Greenwich, CT2.96MShares$3.2 Million0.33% of portfolio
-
Abrdn PLC2.5MShares$2.7 Million0.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $41.7M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...